Article

DNA methylation contributes to loss in productivity of monoclonal antibody-producing CHO cell lines.

Bioprocessing Technology Institute, Agency for Science, Technology and Research (A*STAR), 20 Biopolis Way, #06-01 Centros, Singapore 138668, Singapore.
Journal of biotechnology (impact factor: 2.88). 06/2010; 147(3-4):180-5. DOI:10.1016/j.jbiotec.2010.04.004 pp.180-5
Source: PubMed

ABSTRACT Production instability currently limits the use of mammalian cells for industrial production of therapeutic proteins. We have previously reported that the loss of productivity in recombinant monoclonal antibody producing Chinese Hamster Ovary (CHO-mAb) cell lines is mainly due to a decrease in heavy chain (HC) and light chain (LC) transcripts. Molecular analysis indicates that the decreased mRNA levels are not due to a loss in gene copies and change of integration sites. In this work, we further demonstrate that impaired trans-acting factors and spontaneous mutations to the DNA are not responsible for the reduced HC and LC transcription. Examination of two CpG sites by methyl-assisted quantitative real-time PCR assay revealed an increase in methylation of the human cytomegalovirus major immediate-early enhancer and promoter (hCMV-MIE) controlling the expression of LC and HC in cells which exhibited loss in productivity. Treatment of these cells with a DNA methylation inhibitor, 5-aza-2'-deoxycytidine, partially restored the lost specific mAb productivity. The increase in productivity correlated to the increase in mRNA levels of HC and LC and the demethylation of hCMV-MIE promoter. This finding, which indicates that DNA methylation contributes to production instability, will be beneficial for generation of high-producing cell lines with stable productivity.

0 0
 · 
0 Bookmarks
 · 
64 Views

Keywords

Chinese Hamster Ovary
 
decreased mRNA levels
 
demethylation
 
DNA methylation contributes
 
DNA methylation inhibitor
 
exhibited loss
 
gene copies
 
hCMV-MIE
 
hCMV-MIE promoter
 
heavy chain
 
human cytomegalovirus major immediate-early enhancer
 
impaired trans-acting factors
 
light chain
 
lost specific mAb productivity
 
Molecular analysis
 
mRNA levels
 
productivity correlated
 
recombinant monoclonal antibody
 
reduced HC
 
stable productivity